High-concentration monoclonal antibodies (mAbs) are gaining prominence given the compliance and cost advantages.

At CPHI Europe, Angela Vollstedt, global director of Cell & Gene Therapies at Novartis discussed scale up strategies for cell ...

The Egyptian Drug Authority (EDA) has concluded its participation in activities of CPHI Milan, the premier international ...

The winners of this year’s awards showcase achievements in pharma excellence. CPHI announced the winners of the 2024 Pharma Awards on Oct. 8, 2024 at CPHI Milan in Milan, Italy (1). And the winners ...

Pharmaceutical Technology® Europe spoke with Nicolas Camper, senior director—Bioconjugation Chemistry at Abzena during CPHI Milan. Camper discussed the advancements in conjugation and linker ...

South Korea's leading contract development and manufacturing organization Samsung Biologics said Monday it will participate ...

LONDON, October 10th 2024, - CNX Therapeutics Limited (“CNX Therapeutics”), a speciality  pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines, ...

EXTON, Pa., Oct. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative ...

OneSource Specialty Pharma, a newly formed CDMO, is formed from the merger of three CDMO businesses within the Str ...